Year |
Citation |
Score |
2024 |
Kim S, Lee KW, Yoo Y, Park SH, Lee JW, Jeon S, Illia S, Joshi P, Park HW, Lo HE, Seo J, Kim Y, Chang M, Lee TJ, Seo JB, ... ... Suh SS, et al. and regulate TRAIL-induced drug tolerance in lung cancer. Animal Cells and Systems. 28: 184-197. PMID 38693921 DOI: 10.1080/19768354.2024.2345644 |
0.395 |
|
2022 |
Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, et al. Retraction Notice to: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation. Cancer Cell. PMID 36306794 DOI: 10.1016/j.ccell.2022.10.005 |
0.678 |
|
2022 |
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, et al. Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell. PMID 36306793 DOI: 10.1016/j.ccell.2022.10.006 |
0.701 |
|
2022 |
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, et al. Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell. PMID 36306791 DOI: 10.1016/j.ccell.2022.10.007 |
0.701 |
|
2021 |
Chae HJ, Seo JB, Kim SH, Jeon YJ, Suh SS. Fhit induces the reciprocal suppressions between Lin28/Let-7 and miR-17/92miR. International Journal of Medical Sciences. 18: 706-714. PMID 33437205 DOI: 10.7150/ijms.51429 |
0.316 |
|
2020 |
Khawaled S, Nigita G, Distefano R, Oster S, Suh SS, Smith Y, Khalaileh A, Peng Y, Croce CM, Geiger T, Seewaldt VL, Aqeilan RI. Pleiotropic tumor suppressor functions of WWOX antagonize metastasis. Signal Transduction and Targeted Therapy. 5: 43. PMID 32300104 DOI: 10.1038/S41392-020-0136-8 |
0.424 |
|
2019 |
Khawaled S, Suh SS, Abdeen SK, Monin J, Distefano R, Nigita G, Croce CM, Aqeilan RI. WWOX inhibits metastasis of triple-negative breast cancer cells via modulation of microRNAs. Cancer Research. PMID 30622118 DOI: 10.1158/0008-5472.Can-18-0614 |
0.434 |
|
2018 |
Jeon YJ, Kim T, Park D, Nuovo GJ, Rhee S, Joshi P, Lee BK, Jeong J, Suh SS, Grotzke JE, Kim SH, Song J, Sim H, Kim Y, Peng Y, et al. miRNA-mediated TUSC3 deficiency enhances UPR and ERAD to promote metastatic potential of NSCLC. Nature Communications. 9: 5110. PMID 30504895 DOI: 10.1038/S41467-018-07561-8 |
0.561 |
|
2017 |
Suh SS, Lee SG, Youn UJ, Han SJ, Kim IC, Kim S. Comprehensive Expression Profiling and Functional Network Analysis of Porphyra-334, One Mycosporine-Like Amino Acid (MAA), in Human Keratinocyte Exposed with UV-radiation. Marine Drugs. 15. PMID 28672785 DOI: 10.3390/Md15070196 |
0.348 |
|
2016 |
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell. 30: 349-351. PMID 27505674 DOI: 10.1016/J.Ccell.2016.07.007 |
0.701 |
|
2015 |
Hong JH, Roh KS, Suh SS, Lee S, Sung SW, Park JK, Byun JH, Kang JH. The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26104764 DOI: 10.1007/S13277-015-3428-9 |
0.45 |
|
2015 |
Hong JH, Roh KS, Suh S, Lee SC, Byun JH, Lee Ma, Kang JH. Abstract 3131: Prognostic significance of miR-34a and its inverse correlation with c-MET and CDK6 in lung adenocarcinoma Cancer Research. 75: 3131-3131. DOI: 10.1158/1538-7445.Am2015-3131 |
0.445 |
|
2014 |
Suh SS, Yoo JY, Cui R, Kaur B, Huebner K, Lee TK, Aqeilan RI, Croce CM. FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs. Plos Genetics. 10: e1004652. PMID 25340791 DOI: 10.1371/Journal.Pgen.1004652 |
0.434 |
|
2013 |
Meng W, Ye Z, Cui R, Perry J, Dedousi-Huebner V, Huebner A, Wang Y, Li B, Volinia S, Nakanishi H, Kim T, Suh SS, Ayers LW, Ross P, Croce CM, et al. MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5423-33. PMID 23946296 DOI: 10.1158/1078-0432.Ccr-13-0320 |
0.479 |
|
2013 |
Lautenschlaeger T, Meng W, Ye Z, Cui R, Perry J, Huebner A, Dedousi-Huebner V, Stefano V, Hiroshi N, Kim T, Suh S, Ayers LW, Ross P, Croce CM, Jin V, et al. Lung adenocarcinoma microRNA-31 expression levels to predict lymph node metastasis and patient survival. Journal of Clinical Oncology. 31: 7573-7573. DOI: 10.1200/Jco.2013.31.15_Suppl.7573 |
0.512 |
|
2012 |
Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, Kim T, Bakà cs A, Alder H, Kaur B, Aqeilan RI, Pichiorri F, Croce CM. MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proceedings of the National Academy of Sciences of the United States of America. 109: 5316-21. PMID 22431589 DOI: 10.1073/Pnas.1202465109 |
0.636 |
|
2011 |
Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. The Journal of Experimental Medicine. 208: 875-83. PMID 21518799 DOI: 10.1084/Jem.20110235 |
0.629 |
|
2010 |
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, et al. Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell. 18: 367-81. PMID 20951946 DOI: 10.1016/J.Ccr.2010.09.005 |
0.726 |
|
2009 |
Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, Taccioli C, Pichiorri F, Alder H, Secchiero P, Gasparini P, Gonelli A, Costinean S, Acunzo M, Condorelli G, et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell. 16: 498-509. PMID 19962668 DOI: 10.1016/J.Ccr.2009.10.014 |
0.701 |
|
2009 |
Pichiorri F, Okumura H, Nakamura T, Garrison PN, Gasparini P, Suh SS, Druck T, McCorkell KA, Barnes LD, Croce CM, Huebner K. Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions. The Journal of Biological Chemistry. 284: 1040-9. PMID 19004824 DOI: 10.1074/Jbc.M806638200 |
0.402 |
|
2009 |
Pichiorri F, Suh S, De Luca L, Taccioli C, Benson D, Hofmeister C, Aqeilan R, Croce CM. p53-Inducible Micrornas 192 and 215 Regulate p53 Expression and IGF1 Axis in Multiple Myeloma. Blood. 114: 1973-1973. DOI: 10.1182/Blood.V114.22.1973.1973 |
0.603 |
|
2008 |
Pichiorri F, Palumbo T, Suh SS, Okamura H, Trapasso F, Ishii H, Huebner K, Croce CM. Fhit tumor suppressor: guardian of the preneoplastic genome. Future Oncology (London, England). 4: 815-24. PMID 19086848 DOI: 10.2217/14796694.4.6.815 |
0.426 |
|
2008 |
Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, Munker R, Volinia S, Boccadoro M, Garzon R, Palumbo A, et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 105: 12885-90. PMID 18728182 DOI: 10.1073/Pnas.0806202105 |
0.491 |
|
Show low-probability matches. |